DEA Archived Press Releases

Press Releases before January 20, 2025
1075 Results - Showing 401 to 410
PRESS RELEASE

DEA launches Secure Your Meds campaign, calls on Americans to keep medications safe

WASHINGTON – With families encouraged to stay at home due to the nationwide health crisis, the Drug Enforcement Administration is asking Americans to keep prescription medications safe and secure until they can properly dispose of them. The Secure Your Meds awareness campaign addresses a vital public safety and health issue...
PRESS RELEASE

DEA releases 2020 Drugs of Abuse Resource Guide

WASHINGTON – The U.S. Drug Enforcement Administration has released the 2020 edition of Drugs of Abuse, A DEA Resource Guide , which is designed to be a reliable resource on the most commonly abused and misused drugs in the United States. Released on a periodic basis, Drugs of Abuse provides...
PRESS RELEASE

DEA takes additional steps to allow increased production of controlled substances used in COVID-19 care

WASHINGTON – The Drug Enforcement Administration announced today that it is increasing Aggregate Production Quotas available to pharmaceutical manufacturers for the production of controlled substance medications that are in high demand due to the coronavirus (COVID-19) pandemic. DEA will also approve increases in imports of medications necessary for patients on...
PRESS RELEASE

Pooler pharmacy, pharmacist to pay up to $2.2 million for dispensing illegitimate prescriptions

SAVANNAH, GA: A Savannah-area pharmacy and its pharmacist have agreed to settle federal claims that they unlawfully dispensed controlled substances pursuant to prescriptions by a notorious pill-mill doctor. Under the settlement, Greeson Rx, LLC and Joshua Z. Greeson, of Brooklet, Ga., will pay up to $2.22 million in civil penalties...
PRESS RELEASE

National Prescription Drug Take Back Day Postponed

WASHINGTON – The upcoming National Prescription Drug Take Back Day scheduled for Saturday, April 25, 2020 is postponed due to the ongoing coronavirus (COVID-19) pandemic. DEA will reschedule Take Back Day for a date shortly after the health crisis recedes and national emergency guidelines are lifted. The health and safety...
PRESS RELEASE

Nicolás Maduro Moros and 14 current and former Venezuelan officials charged with narco-terrorism, corruption, drug trafficking and other criminal charges

WASHINGTON – Former president of Venezuela Nicolás Maduro Moros, Venezuela’s vice president for the economy, Venezuela’s minister of defense, and Venezuela’s chief supreme court justice are among those charged in New York City; Washington, D.C.; and Miami, along with current and former Venezuelan government officials and two Fuerzas Armadas Revolucionarias...
PRESS RELEASE

Hayesville, N.C. man sentenced to more than 21 years in federal prison for trafficking in methamphetamine

ASHEVILLE, N.C. – U.S. District Judge Martin Reidinger sentenced Bobby Roger Burch, 48, of Hayesville, N.C. today to 262 months in prison, announced Andrew Murray, U.S. Attorney for the Western District of North Carolina. Judge Reidinger also ordered Burch to serve five years under court supervision upon completion of his...
PRESS RELEASE

Hazlehurst Pharmacy, Pharmacist to pay up to $2.1 million for dispensing thousands of illegitimate prescriptions

BRUNSWICK, GA - A South Georgia pharmacy and its pharmacist have agreed to settle a federal civil suit alleging they unlawfully dispensed thousands of illegitimate prescriptions for opioids and other controlled substances. Under the settlement, announced only weeks after the Southern District of Georgia U.S. Attorney’s Office filed the suit...
PRESS RELEASE

DEA proposes process to expand marijuana research in the United States

WASHINGTON – Today, the Drug Enforcement Administration and the Department of Justice announced action to further expand opportunities for scientific and medical research on marijuana in the United States. The Notice of Proposed Rulemaking provides details on the proposed process and was filed for public inspection today, March 20. The...
PRESS RELEASE

DEA’s response to COVID-19

WASHINGTON – During the unprecedented health emergency caused by the ongoing coronavirus (COVID-19) pandemic, the health and safety of our communities is DEA’s top priority. DEA is responding appropriately to ensure Americans continue to have access to necessary medications and controlled substances. DEA’s efforts include supporting prescribing practices that limit...